Recognized as being of interest to health professionals by the Basque Government’s Department of Health and Consumer Affairs.
Euskalduna Conference Centre and Concert Hall, the technical secretariat Ercisa and the LOC have worked together to make HTAi 2012 Bilbao a 100% sustainable meeting HTAi 2012: A sustainable meeting
Less than one week to start the 2012 Annual Meeting. HTAi2012 final countdown: make your registration.
Find out more news
GRADE: a tool for the development of recommendations in health technology assessments.
Satellite Symposia - Funded by GuiaSalud
The GRADE system classifies recommendations made in guidelines as either strong or weak. GRADE, panels make strong recommendations when they are confident that the desirable effects of adherence to a recommendation outweigh the undesirable effects. Weak recommendations indicate that the desirable effects of adherence to a recommendation probably outweigh the undesirable effects, but the panel is less confident.
GRADE is a systematic and explicit approach make judgments about the quality of evidence and strength of the recommendations in the development of technology assessment.
Local vs. National Health Technology Assessment (HTA); Placing the patient at the centre of the decision making process
Satellite Symposia – Funded by MEDTRONIC
Objectives To discuss the following: - How should local and central HTA coexist in the same system - where are the synergies? - What types of decisions are best taken locally and which centrally? What is the most appropriate research to inform these.
Local health providers, hospitals and primary care organisations, worldwide are moving to systems of localized technology assessment, often in addition to national processes. Such procedures have the potential to facilitate rapid adoption of interventions, which promise clear gains in efficiency, particularly those offering cost savings not requiring substantial up-front investment. However, they may focus disproportionately on net budgetary impact and fail to consider the full lifetime health benefit of treatment. A range of questions therefore exists regarding the correct balance between local and national (and indeed supranational) HTA, and the appropriate methods to be used by each level.
Does Spain Need a NICE?
Satellite Symposia – Funded by AEETS
As Spain proceeds toward a national network of HTA agencies, the experiences of similar organizations should not be overlooked. Of particular interest is the National Institute for Health and Clinical Excellence (NICE), which in little more than a decade has become a paragon of the “fourth hurdle”. Though the HTA program in NICE is excellent in many respects, it is not without its weaknesses; both the achievements and the limitations of NICE can be instructive as we consider the qualities that the HTA program in Spain should embody.
Regional Networks of HTA in the Americas, in Europe and in Asia: what can they learn from each other and what are the opportunities for collaboration.
Satellite Symposia – Funded by ANVISA and PAHO.
The importance of Health Technology Assessment (HTA) is growing as a means to support decision-making about the incorporation of health technologies in the health systems. Three regional networks have emerged to support the strengthening of HTA in the Americas (RedETSA), Europe (EUnetHTA) and Asia (HTAsiaLink). Experiences of the collaboration in HTA among the networks’ members will be presented and opportunities for collaboration between the networks will be explored. As a way of facilitating the debate among the session attendees, representatives of INAHTA and HTAi will comment the presentations and moderate the debate.
The European network for Health Technology Assessment (EUnetHTA) grew organically from international collaboration among HTA researchers and policy processes in EU Member States (MS) and the European Commission. EUnetHTA is a practically oriented collaboration between MS institutions with EU support since 2006. Tools and instruments for scientific collaboration are developed and tested through careful piloting. EUnetHTA currently comprises 34 HTA institutions from 24 EU member states, Norway and Croatia.
The HTAsiaLink was established in 2010 as a collaboration between HTA organizations in Asia. Six institutes in 5 countries: Japan, Korea, Malaysia, Taiwan and Thailand are involved in the network, which aims to strengthen individual and institutional capacity in HTA research and enhance the integration of evidence into policy decisions. The objective will be achieved through information exchange, joint research projects, annual conference and other collective activities. Transfer of lessons learned is also expected between HTAsiaLink and HTA networks and organizations in other settings.
RedETSA, the HTA Network of the Americas, was launched in June 2011, when Representatives from 13 countries and a total of 20 institutions (Ministries of Health, PAHO/WHO Collaborating Centers and other centers for excellence in the Region) agreed to form the network. PAHO, the Pan-American Health Organization, acts as the Secretariat of RedETSA. The Network shall promote and strengthen HTA, through regional exchange as a tool to support decision-making on the introduction, dissemination and use of technologies; advance the adoption of common methodologies; and establish joint working priorities for capacity building.
Can Industry Involvement improve HTA outcomes?
Satellite Symposia – AESGP, COCIR, EDMA, EFPIA, Eucomed and EuropaBio
Objectives and Outline: HTA agencies and HTA stakeholders seem to agree that there is value in involving stakeholders in the HTA process. This is even embodied in the European legislation with article 15 of Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare which states that Union funds should be used to “) facilitate the consultation of stakeholders on the work of the network”. However, HTA agencies and HTA stakeholders often seem to disagree on the degree to which stakeholder involvement should be realised, ranging from a simple consultation of stakeholders’ views to inclusive engagement in all parts of the HTA process. In particular, HTA agencies seem to be concerned about the degree to which they should involve industry in their processes, as they seem to see a risk that their independence could be compromised which in turn could compromise their effectiveness and the validity of their findings. At the same time, industry develops the technologies that are being assessed and is thus in possession of key information and data. The question is therefore how industry involvement should be captured to bring greatest value to the HTA process. This interactive workshop will provide a platform for discussion on the appropriate degree of industry involvement in the development and conduct of HTA processes.
Quick & Cloud: integrated technologies and real time registries. A new opportunity for HTA?
Satellite Symposia – EuropaBio
Background: Innovations in integrated technologies and individualized care have the potential to dramatically change healthcare, in a way that could make current HTA methodologies obsolete. A new approach is developing in which the patient is at the core of information generation and decision processes. How can HTA take advantage of the incredible opportunities coming from real time data collection on administration, response to treatment, patient preferences and outcomes? What will be the challenges to be overcome and risks for HTA of being replaced by quicker assessment/decision approaches?
The focus of Chronicity in a system of integrated health care and patient centered.
Satellite Symposia – OSTEBA and AIAQS
Role of Agencies for Health Technology Assessment in the process of updating and improving the core/basic service portfolio of the NHS.
Satellite Symposia – Ministry of Health, Social Affairs & Equality
Methodological tools and resources development to enhance networking in Health Technology Assessment. Presentation of the Spanish Network of Agencies for Health Technology Assessment in the NHS.
Medical nutrition: a cost-effective pilar in therapeutic interventions.
Satellite Symposia – Funded by Nestlé.
The aim of this symposium is to raise the awareness on medical nutrition in therapeutic interventions and to demonstrate that they bring value-for-money to healthcare systems. Indeed, introduction of medical nutrition interventions into therapeutic protocol of care should be a focus of HTA, as medical nutrition interventions are a pillar into cost-effective therapeutic protocol.